Book Now
When metabolic signaling is off, so is weight regulation. GLP-1 influences appetite regulation, insulin signaling, and metabolic efficiency.
Medical Weight Loss
Care begins with a detailed health history review and appropriate diagnostic testing to determine eligibility and establish baseline metabolic health.
When clinically appropriate, GLP-1 therapy is initiated at carefully selected doses based on tolerance and adherence.
Medication is integrated with nutrition strategy, lifestyle guidance, and metabolic considerations to support sustainable progress.
Regular check-ins and follow-up assessments allow dosing and strategy to adapt based on response, side effects, and evolving goals.
Peptide therapy is integrated into a broader longevity strategy — adapting over time as your biology evolves and your goals expand.
GLP-1 therapy supports natural satiety signaling, reducing persistent hunger and food noise that often contributes to weight gain.
Clinician-guided programs prioritize metabolic health to reduce rebound weight gain.
By improving insulin response and energy utilization, GLP-1 can support sustainable fat loss.
GLP-1 therapy supports natural satiety signaling, reducing persistent hunger and food noise that often contributes to weight gain.
Clinician-guided programs prioritize metabolic health to reduce rebound weight gain.
By improving insulin response and energy utilization, GLP-1 can support sustainable fat loss.
Our treatments use a full-system approach to uncover the root cause of condition and apply the most advanced therapies available. Peptide therapy, in particular, supports multiple systems to promote whole-body healing and long-term relief.
Appetite and food noise regulation
Sustainable fat loss and metabolic traction
Maintenance strategy and long-term stability
Support Your Body with Cutting-Edge Therapy
GLP-1 therapy is used in support of metabolic signaling and insulin regulation, not a standalone appetite suppressant or cosmetic intervention.
Medication selection, titration, and duration are guided by your provider and adjusted based on response and tolerance.
Weight loss strategies prioritize fat reduction while protecting muscle mass, energy levels, and overall performance.
Programs are designed with maintenance and transition strategies in mind, reducing rebound risk and supporting long-term success.
Most medical weight loss programs rely on basic prescriptions and generic calorie-driven plans which overlooks the deeper drivers of weight regulation like insulin signaling, metabolic adaptation, inflammation, thyroid function, appetite hormones, and stress physiology, often resulting in temporary or inconsistent results.
Humanaut's model closes these gaps through depth, context, and iteration.
Medical weight loss is a clinician-guided program designed to improve metabolic health and support sustainable fat loss. Treatment may include GLP-1 therapy alongside personalized nutrition, lifestyle strategy, and ongoing clinical monitoring.
GLP-1 receptor agonists are prescription medications that influence appetite regulation, satiety signaling, and insulin response. They support weight loss by helping reduce persistent hunger and improving metabolic efficiency.
GLP-1 therapy works by enhancing natural fullness signals, reducing food noise, slowing gastric emptying, and supporting healthier blood sugar regulation. When used appropriately, it can help create sustainable fat loss without extreme restriction.
This program may be appropriate for individuals with weight gain resistant to diet and exercise, metabolic inefficiency, insulin resistance, persistent hunger, or weight-related health risk factors. Eligibility is determined through clinical evaluation.
Weight regain is possible if metabolic and behavioral factors are not addressed. Humanaut programs emphasize long-term metabolic support, maintenance planning, and transition strategies to promote durable outcomes beyond medication use.
Duration varies based on individual goals, response, and clinical context. Some individuals use GLP-1 therapy short-term, while others benefit from longer-term support. Treatment plans are continuously reassessed over time.
Yes. GLP-1 therapy may be offered through structured weight loss programs or integrated into ongoing membership care for long-term metabolic optimization and clinical oversight.
Fill out the form and we'll get back to you.
